Treatments for seizures in catamenial (menstrual-related) epilepsy.
CONCLUSIONS: This review provides very low-certainty evidence of no treatment difference between norethisterone and placebo, and moderate- to low-certainty evidence of no treatment difference between progesterone and placebo for catamenial epilepsy. However, as all the included studies were underpowered, important clinical effects cannot be ruled out.Our review highlighted an overall deficiency in the literature base on the effectiveness of a wide range of other hormonal and non-hormonal interventions currently being used in practice, particularly for those patients who do not have regular menses. Further clinical trials are needed in this area.
PMID: 31608992 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - Category: General Medicine Authors: Maguire MJ, Nevitt SJ Tags: Cochrane Database Syst Rev Source Type: research
More News: Acetazolamide | Brain | Cardiology | Cardiovascular | Clinical Trials | Common Cold | Databases & Libraries | Depression | Diarrhoea | Dyspepsia | Epilepsy | General Medicine | Headache | Heart | Hormones | International Medicine & Public Health | Medroxyprogesterone | Men | Migraine | Neurology | Neurosurgery | Orthopaedics | Osteoporosis | Reproduction Medicine | Study | WHO | Women